Gavin Screaton to Middle Aged
                                
                                
                                    This is a "connection" page, showing publications Gavin Screaton has written about Middle Aged.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.020
         
        
        
     
 
    
        
        - 
            Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021 08; 8(8):e474-e485.
            
            
                Score: 0.004
             
- 
            Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections. BMC Infect Dis. 2021 Feb 18; 21(1):187.
            
            
                Score: 0.004
             
- 
            Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N Engl J Med. 2021 02 11; 384(6):533-540.
            
            
                Score: 0.004
             
- 
            SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020. Euro Surveill. 2020 10; 25(42).
            
            
                Score: 0.004
             
- 
            Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. Elife. 2020 08 21; 9.
            
            
                Score: 0.004
             
- 
            T cell responses to whole SARS coronavirus in humans. J Immunol. 2008 Oct 15; 181(8):5490-500.
            
            
                Score: 0.002